Together we are beating cancer

Donate now

Hodgkin lymphoma

Showing 11 out of 11 results
Senedd Cymru, or the Welsh Parliament.

Health inequalities in Wales put deprived communities more at risk of cancer. The All Things Being Equal inquiry shows what has to change. Health inequalities in Wales put deprived communities more at risk of cancer. The All Things Being Equal inquiry shows what has to change.

by Tim Gunn | News | 8 June 2023

8 June 2023

Lab equipment at our Experimental Cancer Medicine Centre in Southampton
  • Science & Technology
  • Health & Medicine

3 ways we're helping teenagers and young adults with cancer

Teenagers and young adults with cancer have to deal with unique challenges. We're using our expertise to help tackle them. Teenagers and young adults with cancer have to deal with unique challenges. We're using our expertise to help tackle them.

by Tim Gunn | In depth | 18 April 2023

18 April 2023

Lung cancer cells

Three new cancer drugs have been given the go-ahead by the Scottish Medicines Consortium (SMC) for routine use in Scotland, two for non small cell lung cancer and one for Hodgkin lymphoma, but a fourth has been rejected. Three new cancer drugs have been given the go-ahead by the Scottish Medicines Consortium (SMC) for routine use in Scotland, two for non small cell lung cancer and one for Hodgkin lymphoma, but a fourth has been rejected.

by Harry Jenkins | News | 11 November 2021

11 November 2021

PET lymphoma scan

Hodgkin lymphoma patients can be spared the serious side effects of chemotherapy thanks to high-tech scans that can predict the outcome of treatment. Hodgkin lymphoma patients can be spared the serious side effects of chemotherapy thanks to high-tech scans that can predict the outcome of treatment.

by Cancer Research UK | News | 22 June 2016

22 June 2016

Cancer Research UK logo

TWO THIRDS of Hodgkin's lymphoma patients treated with an experimental radioactive cancer therapy responded well to the treatment, reveal the results of a Cancer Research UK phase I trial published in Clinical Cancer Research*, today (Tuesday). TWO THIRDS of Hodgkin's lymphoma patients treated with an experimental radioactive cancer therapy responded well to the treatment, reveal the results of a Cancer Research UK phase I trial published in Clinical Cancer Research*, today (Tuesday).

by Cancer Research UK | News | 15 December 2009

15 December 2009

Cancer Research UK logo

Cases of non-Hodgkin lymphoma have more than tripled in the last thirty years according to the latest Cancer Research UK figures published today. Cases of non-Hodgkin lymphoma have more than tripled in the last thirty years according to the latest Cancer Research UK figures published today.

by Cancer Research UK | News | 2 September 2009

2 September 2009

Cancer Research UK logo

Children treated for Hodgkin's disease before 1986 have an increased risk of developing another cancer later in life, according to a new study1 by an international team of researchers including scientists from Cancer Research UK. Children treated for Hodgkin's disease before 1986 have an increased risk of developing another cancer later in life, according to a new study1 by an international team of researchers including scientists from Cancer Research UK.

by Cancer Research UK | News | 28 November 2003

28 November 2003